Renaissance Technologies’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $452K | Buy |
149,200
+19,800
| +15% | +$60K | ﹤0.01% | 2884 |
|
2025
Q1 | $551K | Sell |
129,400
-12,900
| -9% | -$55K | ﹤0.01% | 2702 |
|
2024
Q4 | $751K | Sell |
142,300
-194,440
| -58% | -$1.03M | ﹤0.01% | 2639 |
|
2024
Q3 | $616K | Buy |
336,740
+186,340
| +124% | +$341K | ﹤0.01% | 2688 |
|
2024
Q2 | $313K | Buy |
150,400
+65,800
| +78% | +$137K | ﹤0.01% | 2894 |
|
2024
Q1 | $339K | Sell |
84,600
-28,700
| -25% | -$115K | ﹤0.01% | 3038 |
|
2023
Q4 | $212K | Buy |
113,300
+53,200
| +89% | +$99.5K | ﹤0.01% | 3114 |
|
2023
Q3 | $100K | Sell |
60,100
-23,500
| -28% | -$39.1K | ﹤0.01% | 3247 |
|
2023
Q2 | $200K | Buy |
83,600
+24,694
| +42% | +$59.1K | ﹤0.01% | 3305 |
|
2023
Q1 | $184K | Sell |
58,906
-8,094
| -12% | -$25.3K | ﹤0.01% | 3305 |
|
2022
Q4 | $180K | Sell |
67,000
-12,200
| -15% | -$32.8K | ﹤0.01% | 3454 |
|
2022
Q3 | $234K | Buy |
79,200
+25,000
| +46% | +$73.9K | ﹤0.01% | 3319 |
|
2022
Q2 | $159K | Buy |
54,200
+16,600
| +44% | +$48.7K | ﹤0.01% | 3732 |
|
2022
Q1 | $192K | Sell |
37,600
-27,200
| -42% | -$139K | ﹤0.01% | 3662 |
|
2021
Q4 | $437K | Sell |
64,800
-51,100
| -44% | -$345K | ﹤0.01% | 3140 |
|
2021
Q3 | $802K | Buy |
115,900
+64,473
| +125% | +$446K | ﹤0.01% | 2669 |
|
2021
Q2 | $501K | Buy |
51,427
+20,027
| +64% | +$195K | ﹤0.01% | 2964 |
|
2021
Q1 | $494K | Buy |
31,400
+14,290
| +84% | +$225K | ﹤0.01% | 2909 |
|
2020
Q4 | $414K | Sell |
17,110
-20,676
| -55% | -$500K | ﹤0.01% | 2904 |
|
2020
Q3 | $636K | Buy |
37,786
+7,800
| +26% | +$131K | ﹤0.01% | 2735 |
|
2020
Q2 | $879K | Buy |
29,986
+4,100
| +16% | +$120K | ﹤0.01% | 2605 |
|
2020
Q1 | $595K | Buy |
25,886
+4,783
| +23% | +$110K | ﹤0.01% | 2672 |
|
2019
Q4 | $346K | Buy |
21,103
+1,917
| +10% | +$31.4K | ﹤0.01% | 3032 |
|
2019
Q3 | $200K | Buy |
19,186
+1,613
| +9% | +$16.8K | ﹤0.01% | 3148 |
|
2019
Q2 | $292K | Buy |
17,573
+6,179
| +54% | +$103K | ﹤0.01% | 3181 |
|
2019
Q1 | $229K | Buy |
11,394
+3,429
| +43% | +$68.9K | ﹤0.01% | 3171 |
|
2018
Q4 | $723K | Sell |
7,965
-445
| -5% | -$40.4K | ﹤0.01% | 2719 |
|
2018
Q3 | $656K | Buy |
8,410
+748
| +10% | +$58.3K | ﹤0.01% | 2765 |
|
2018
Q2 | $751K | Buy |
7,662
+1,759
| +30% | +$172K | ﹤0.01% | 2700 |
|
2018
Q1 | $590K | Buy |
5,903
+865
| +17% | +$86.5K | ﹤0.01% | 2856 |
|
2017
Q4 | $383K | Buy |
5,038
+740
| +17% | +$56.3K | ﹤0.01% | 2950 |
|
2017
Q3 | $344K | Buy |
4,298
+1,193
| +38% | +$95.5K | ﹤0.01% | 2875 |
|
2017
Q2 | $189K | Buy |
3,105
+1,792
| +136% | +$109K | ﹤0.01% | 3004 |
|
2017
Q1 | $92K | Buy |
1,313
+550
| +72% | +$38.5K | ﹤0.01% | 3090 |
|
2016
Q4 | $58K | Buy |
+763
| New | +$58K | ﹤0.01% | 3155 |
|